Published in Vaccine Weekly, November 21st, 2007
These results have prompted Sanofi Pasteur to immediately expand ongoing clinical trials in Asia and Latin America. Submission to health authorities for registration is anticipated in 2012.
"Sanofi Pasteur made research for a vaccine against dengue fever one of its top priorities...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly